Tyrosine kinase inhibitors are potent and selective inhibitors of UGT1A1: Tools for UGT phenotyping

被引：0
作者：
Kalyanaraman, Nataraj
Li, Chun
Surapaneni, Sekhar S.
Kumar, Gondi N.
机构：
[1] Amgen Inc, PKDM, Thousand Oaks, CA 91320 USA
[2] Amgen Inc, Dept PKDM MS, Newbury Pk, CA USA
[3] Amgen Inc, Dept PKDM MS, Thousand Oaks, CA 91320 USA
来源：
DRUG METABOLISM REVIEWS | 2006年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
74
引用
收藏
页码：43 / 43
页数：1
相关论文
共 50 条
[41]   Interethnic Variations of UGT1A1 and UGT1A7 Polymorphisms in the Jordanian Population [J].
Abudahab, Sara ;
Hakooz, Nancy ;
Jarrar, Yazun ;
Al Shhab, Mohammad ;
Saleh, Ahmad ;
Zihlif, Malek ;
Dajani, Rana .
CURRENT DRUG METABOLISM, 2019, 20 (05) :399-410
[42]   Phenotyping of UGT1A1 Activity Using Raltegravir Predicts Pharmacokinetics and Toxicity of Irinotecan in FOLFIRI [J].
Lee, Lawrence Soon-U ;
Seng, Kok-Yong ;
Wang, Ling-Zhi ;
Yong, Wei-Peng ;
Hee, Kim-Hor ;
Soh, Thomas I. ;
Wong, Andrea ;
Cheong, Pei F. ;
Soong, Richie ;
Sapari, Nur S. ;
Soo, Ross ;
Fan, Lu ;
Lee, Soo-Chin ;
Goh, Boon C. .
PLOS ONE, 2016, 11 (01)
[43]   UGT1A1*6 AND UGT1A1*27 ARE ASSOCIATED WITH IRINOTECAN-INDUCED SEVERE NEUTROPENIA IN JAPANESE PATIENTS WITH NSCLC [J].
Doi, S. ;
Nakamura, Y. ;
Fukuda, M. ;
Takatani, H. ;
Fukuda, M. ;
Kinoshita, A. ;
Soda, H. ;
Oka, M. ;
Tsukamoto, K. ;
Kohno, S. .
ANNALS OF ONCOLOGY, 2008, 19 :165-165
[44]   Effects of Shengjiangxiexin decoction on irinotecan-induced toxicity in patients with UGT1A1*28 and UGT1A1*6 polymorphisms [J].
Deng Bo ;
Jia Liqun ;
Tan Huangying ;
Lou Yanni ;
Li Xue ;
Li Yuan ;
Yu Lili .
JournalofTraditionalChineseMedicine, 2017, 37 (01) :35-42
[45]   UGT1A1*6 and UGT1A1*28 polymorphisms are correlated with irinotecan-induced toxicity: A meta-analysis [J].
Yang, Yuwei ;
Zhou, MengMeng ;
Hu, Mingjun ;
Cui, Yanjie ;
Zhong, Qi ;
Liang, Ling ;
Huang, Fen .
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 (05) :e479-e489
[46]   METABOLISM OF PICEATANNOL IN HUMAN LIVER MICROSOMES: MAJOR ROLE OF UGT1A1, UGT1A8 AND UGT1A10 [J].
Vo, Nha T. P. ;
Miksits, Michaela ;
Maier-Salamon, Alexandra ;
Szekeres, Thomas ;
Jaeger, Walter .
DRUG METABOLISM REVIEWS, 2007, 39 :187-187
[47]   Glucuronidation of piceatannol by human liver microsomes: major role of UGT1A1, UGT1A8 and UGT1A10 [J].
Miksits, Michaela ;
Maier-Salamon, Alexandra ;
Thanh Phuong Nha Vo ;
Sulyok, Michael ;
Schuhmacher, Rainer ;
Szekeres, Thomas ;
Jaeger, Walter .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2010, 62 (01) :47-54
[48]   THE POLYMORPHISMS OF UGT1A1 AND UGT1A6 INFLUENCE ACETAMINOPHEN METABOLISM AND BILIRUBIN IN VIVO [J].
Guo, Dong ;
Zhou, Honghao .
DRUG METABOLISM REVIEWS, 2008, 40 :156-156
[49]   The association of UGT1A1*6 and UGT1A1*28 with irinotecan-induced neutropenia in Asians: a meta-analysis [J].
Chen, Yi-Jing ;
Hu, Fei ;
Li, Chun-Yan ;
Fang, Jue-Min ;
Chu, Li ;
Zhang, Xi ;
Xu, Qing .
BIOMARKERS, 2014, 19 (01) :56-62
[50]   Humanized UGT1*28 Mice for Assessing UGT1A1 dependent glucuronidation and Clearance [J].
Yang, Young-Sun ;
Peterkin, Vincent ;
Cai, Hongliang ;
Hotz, Kathy ;
Nguyen, Nghia ;
La Placa, Deirdre ;
Tukey, Robert H. ;
Stevens, Jeffrey C. .
DRUG METABOLISM REVIEWS, 2009, 41 :39-40
12345